PEPTONIC medical AB (publ) (XSAT:PMED)

PEPTONIC medical AB Statistics

Total Valuation

XSAT:PMED has a market cap or net worth of SEK 92.09 million. The enterprise value is 88.54 million.

Market Cap	92.09M
Enterprise Value	88.54M

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

XSAT:PMED has 1.53 billion shares outstanding. The number of shares has increased by 134.00% in one year.

Current Share Class	1.53B
Shares Outstanding	1.53B
Shares Change (YoY)	+134.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.72%
Owned by Institutions (%)	24.56%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.23
PB Ratio	2.41
P/TBV Ratio	3.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.94
EV / Sales	5.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.49, with a Debt / Equity ratio of 0.25.

Current Ratio	0.49
Quick Ratio	0.26
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.29

Financial Efficiency

Return on equity (ROE) is -51.83% and return on invested capital (ROIC) is -22.35%.

Return on Equity (ROE)	-51.83%
Return on Assets (ROA)	-17.81%
Return on Invested Capital (ROIC)	-22.35%
Return on Capital Employed (ROCE)	-50.85%
Weighted Average Cost of Capital (WACC)	6.24%
Revenue Per Employee	7.39M
Profits Per Employee	-11.25M
Employee Count	2
Asset Turnover	0.22
Inventory Turnover	0.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.93% in the last 52 weeks. The beta is -0.00, so XSAT:PMED's price volatility has been lower than the market average.

Beta (5Y)	-0.00
52-Week Price Change	-43.93%
50-Day Moving Average	0.06
200-Day Moving Average	0.07
Relative Strength Index (RSI)	50.31
Average Volume (20 Days)	936,467

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XSAT:PMED had revenue of SEK 14.79 million and -22.50 million in losses. Loss per share was -0.00.

Revenue	14.79M
Gross Profit	9.95M
Operating Income	-19.45M
Pretax Income	-22.50M
Net Income	-22.50M
EBITDA	-17.52M
EBIT	-19.45M
Loss Per Share	-0.00

Balance Sheet

The company has 195,000 in cash and 9.43 million in debt, with a net cash position of -9.23 million or -0.01 per share.

Cash & Cash Equivalents	195,000
Total Debt	9.43M
Net Cash	-9.23M
Net Cash Per Share	-0.01
Equity (Book Value)	38.25M
Book Value Per Share	0.00
Working Capital	-14.03M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	1.93M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 67.30%, with operating and profit margins of -131.52% and -152.12%.

Gross Margin	67.30%
Operating Margin	-131.52%
Pretax Margin	-152.12%
Profit Margin	-152.12%
EBITDA Margin	-118.46%
EBIT Margin	-131.52%
FCF Margin	n/a

Dividends & Yields

XSAT:PMED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-134.00%
Shareholder Yield	-134.00%
Earnings Yield	-24.43%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XSAT:PMED has an Altman Z-Score of -9.05 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.05
Piotroski F-Score	1